Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Company receives CE Mark approval for UniStar cobalt chromium stent
June 6th, 2005
Conor Medsystems, Inc., (CONR) announced that its UniStar cobalt chromium bare-metal coronary stent received Conformite Europeenne (CE) Mark approval in the European Community for the treatment of de novo coronary artery lesions. Conor also announced that the company has received Organization for Standardization (ISO) certification of its facility in Athlone, Ireland for the commercial manufacturing of its proprietary coronary stents including the UniStar stent and the CoStar cobalt chromium paclitaxel-eluting coronary stent. "We are delighted to have received CE Mark approval for UniStar, which lays the foundation for European regulatory approval of...
Source: Biotech Business Week (2005-06-06)
|
